Canada vs Ecuador: Confirmed cases of MDR-TB started treatment for MDR-TB
Canada
89.0%
in 2012
Ecuador
86.0%
in 2012
Canada rank
27th
Ecuador rank
29th
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Canada
- Ecuador
How they compare
Canada currently reports 89.0% against 86.0% in Ecuador, a difference of 3.0%.
The two have swapped places 1 time across 5 shared years of data; in 2008 it was Ecuador ahead.
Canada ranks 27th and Ecuador ranks 29th of 54 countries.
Across the 2 decades both report, Canada averaged higher in 1 and Ecuador in 1.
Head to head by decade
| Decade | Canada | Ecuador | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 85.5% | 212.5% | 127.0% | Ecuador |
| 2010s | 94.7% | 77.0% | 17.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Canada or Ecuador?
- Canada, at 89.0% against 86.0% in Ecuador as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Canada and Ecuador?
- 3.0%, with Canada ahead.
- How many years of comparable data are there for Canada and Ecuador?
- 5 years are reported by both, from 2008 to 2012.
- How do Canada and Ecuador rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Canada ranks 27th and Ecuador ranks 29th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.